Calvani, Riccardo http://orcid.org/0000-0001-5472-2365
Picca, Anna http://orcid.org/0000-0001-7032-3487
Marini, Federico http://orcid.org/0000-0001-8266-1117
Biancolillo, Alessandra http://orcid.org/0000-0002-9461-9597
Gervasoni, Jacopo http://orcid.org/0000-0002-3600-392X
Persichilli, Silvia http://orcid.org/0000-0002-7955-8810
Primiano, Aniello http://orcid.org/0000-0001-9415-9175
Coelho-Junior, Hélio J. http://orcid.org/0000-0001-7482-9514
Cesari, Matteo http://orcid.org/0000-0002-0348-3664
Bossola, Maurizio http://orcid.org/0000-0003-1627-0235
Urbani, Andrea http://orcid.org/0000-0001-9168-3174
Onder, Graziano http://orcid.org/0000-0003-3400-4491
Landi, Francesco http://orcid.org/0000-0002-3472-1389
Bernabei, Roberto http://orcid.org/0000-0002-9197-004X
Marzetti, Emanuele http://orcid.org/0000-0001-9567-6983
Funding for this research was provided by:
Fondazione Roma (NCDs Call for Proposals 2013)
Innovative Medicines Initiative (115621)
Centro Studi Achille e Linda Lorenzon (N/A)
Università Cattolica del Sacro Cuore (D3.2 2013, D3.2 2015)
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (001)
Article History
Received: 15 January 2020
Accepted: 28 April 2020
First Online: 1 June 2020
Compliance with ethical standards
:
: A.P., E.M., F.L., M.C., and R.C. are partners of the SPRINTT consortium, which is partly funded by the European Federation of Pharmaceutical Industries and Associations (EFPIA).E.M. served as a consultant for Abbott, Biophytis, Nutricia, and Nestlè. R.C. served as a consultant for Abbott and Nutricia. M.C. served as a consultant for and/or received honoraria for scientific presentations from Nestlé and received a research grant from Pfizer.